Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Incidence of Thyroid Cancer

Summary Indicator Report Data View Options

Year199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020210.05.010.015.020.025.030.035.0Age-adjusted Rate per 100,000 PopulationIncidence of Thyroid Cancer by Year and Sex, 1990 to 2021MaleFemale

Incidence of Thyroid Cancer by County, Males, 2017-2021

Base Map

Overlays

Labels

Choropleth

×

Age-adjusted Rate per 100,000 Males

30 km
20 mi
Leaflet | © OpenStreetMap contributors

Incidence of Thyroid Cancer by County, Females, 2017-2021

Base Map

Overlays

Labels

Choropleth

×

Age-adjusted Rate per 100,000 Females

30 km
20 mi
Leaflet | © OpenStreetMap contributors

Why Is This Important?

During 2021, 429 male and 1,325 female New Jersey residents were diagnosed with thyroid cancer. Thyroid cancer is different than many adult cancers in that it occurs about 3 times more often in women than in men, and it is more frequently diagnosed in younger adults.

Definition

Incidence rate of invasive thyroid cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.

Data Sources

How the Measure is Calculated

Numerator:Number of new cases of thyroid cancer among a defined population in a specified time interval.
Denominator:Defined population in a specified time interval.

How Are We Doing?

Between 1990 and 2021, the age-adjusted thyroid cancer rate in females rose from 6.9 cases per 100,000 to 26.3 cases per 100,000. In males, the increase was smaller, from 2.9 cases per 100,000 to 8.4 cases per 100,000 in 2020. The reason for the sharp increase in thyroid cancer incidence rates, especially in recent years, is unknown. Theorized explanations include increased diagnosis of thyroid cancer by medical practitioners and increased prevalence of possible risk factors such as diagnostic radiation and obesity. The lifetime risk of developing thyroid cancer is 1 in 153 for men and 1 in 58 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. https://www.nj.gov/health/ces/public/resources/occp.shtml

Available Services

The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention.

Cancer Epidemiology Services: https://nj.gov/health/ces/

Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml

Office of Cancer Control and Prevention: https://www.nj.gov/health/ces/public/resources/occp.shtml

NJ Cancer Education and Early Detection (NJCEED): https://www.nj.gov/health/ces/public/resources/njceed.shtml

NJ Commission on Cancer Research: https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml

More Resources

More information on thyroid cancer is available from the NJ State Cancer Registry: https://nj.gov/health/ces/documents/briefs/thyroid_cancer_incidence_bystage.pdf, and https://nj.gov/health/ces/documents/briefs/thyroid_cancer_survival_byrace_eth.pdf.

Indicator Data Last Updated On 11/01/2024, Published on 11/06/2024
Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov (https://www.nj.gov/health/ces)